Over the 90-day window ending January 02, 2026, Sonoma Pharmaceuticals's three dominant insider ownership positions are held by Executive Vice President Bruce Thornton (7.72K shares), Chief Executive Officer Amy Moss Trombly (7.68K shares), Chief Financial Officer Jerome J Dvonch (4.23K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bruce Thornton | Executive Vice President | 7,721 | 21 Jun, 2024 |
| Amy Moss Trombly | Chief Executive Officer | 7,679 | 21 Jun, 2024 |
| Jerome J Dvonch | Chief Financial Officer | 4,230 | 21 Jun, 2024 |
| Poggetto John Dal | Controller | 750 | 21 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Jun, 2024 | Amy Moss Trombly | Common Stock, $0.0001 par value | A | 53,586 | - | 7,679 | D | A |
| 20 Jun, 2024 | Jerome J Dvonch | Common Stock, $0.0001 par value | A | 53,586 | - | 4,230 | D | A |
| 20 Jun, 2024 | Poggetto John Dal | Common Stock, $0.0001 par value | A | 15,000 | - | 750 | D | A |
| 20 Jun, 2024 | Bruce Thornton | Common Stock, $0.0001 par value | A | 53,586 | - | 7,721 | D | A |
| 30 Jun, 2023 | Bruce Thornton | Common Stock, $0.0001 par value | A | 100,000 | - | 10,839 | D | A |
| 30 Jun, 2023 | Amy Moss Trombly | Common Stock, $0.0001 par value | A | 100,000 | - | 10,682 | D | A |
| 23 Apr, 2020 | Poggetto John Dal | Common Stock, $0.0001 par value | A | 3,086 | - | 160 | D | A |
| 23 Apr, 2020 | Robert Grant Edwards | Common Stock, $0.0001 par value | A | 2,609 | - | 130 | D | A |
| 23 Apr, 2020 | Robert Grant Edwards | - | - | 130 | D | |||
| 30 May, 2018 | Jay E Birnbaum | Common Stock, $0.0001 par value per share | A | 1,052 | - | 14 | D | A |
| 30 May, 2018 | Russell Joseph Harrison | Common Stock, $0.0001 par value per share | A | 1,538 | - | 13 | D | A |
| 30 May, 2018 | John Mclaughlin | - | - | 14 | D | |||
| 30 May, 2018 | John Mclaughlin | Common Stock, $0.0001 par value per share | A | 1,781 | - | 14 | D | A |
| 12 Mar, 2018 | Robert E Miller | Common Stock, $0.0001 par value per share | A | 1,200 | $4.03 | 5 | I | P |
| 13 Mar, 2018 | Robert E Miller | Common Stock, $0.0001 par value per share | A | 1,200 | $4.10 | 5 | I | P |
| 09 Mar, 2018 | Robert E Miller | Common Stock, $0.0001 par vlue per share | A | 1,200 | $3.90 | 4 | I | P |
| 09 Mar, 2018 | Robert E Miller | - | - | 4 | I | |||
| 12 Mar, 2018 | Robert E Miller | Common Stock, $0.0001 par vlue per share | A | 1,200 | $4.03 | 5 | I | P |
| 12 Mar, 2018 | Robert E Miller | - | - | 5 | I | |||
| 08 Mar, 2018 | James J Schutz | Common Stock, $0.0001 par value per share | A | 2,473 | $3.99 | 10 | D | P |